Wells Fargo & Company Procaps Group, S.A. Transaction History

Wells Fargo & Company

  • $429 Billion
  • Q1 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$8.85 - $10.42 $2,212 - $2,605
-250 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.25 - $10.76 $2,312 - $2,690
250 New
250 $3,000

Others Institutions Holding PROC

# of Institutions
1
Shares Held
14K
Call Options Held
0
Put Options Held
0
View Full List

About Procaps Group, S.A.

PROC Quotes by TradingView
  • Ticker PROC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 112,824,000
  • Market Cap $103M
  • Description
  • Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...
More about PROC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email